HRP20130618T1 - Methods of using mirna for detection of in vivo cell death - Google Patents

Methods of using mirna for detection of in vivo cell death

Info

Publication number
HRP20130618T1
HRP20130618T1 HRP20130618AT HRP20130618T HRP20130618T1 HR P20130618 T1 HRP20130618 T1 HR P20130618T1 HR P20130618A T HRP20130618A T HR P20130618AT HR P20130618 T HRP20130618 T HR P20130618T HR P20130618 T1 HRP20130618 T1 HR P20130618T1
Authority
HR
Croatia
Prior art keywords
cell death
detection
mirna
methods
vivo cell
Prior art date
Application number
HRP20130618AT
Other languages
English (en)
Inventor
Eugene M. Shekhtman
Hovsep S. Melkonyan
Samuil R. Umansky
Vladimir S. Scheinker
Original Assignee
Trovagene, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40378881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20130618(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Trovagene, Inc. filed Critical Trovagene, Inc.
Publication of HRP20130618T1 publication Critical patent/HRP20130618T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HRP20130618AT 2007-08-22 2013-07-02 Methods of using mirna for detection of in vivo cell death HRP20130618T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96587107P 2007-08-22 2007-08-22
PCT/US2008/009991 WO2009025852A2 (en) 2007-08-22 2008-08-22 Methods of using mirna for detection of in vivo cell death

Publications (1)

Publication Number Publication Date
HRP20130618T1 true HRP20130618T1 (en) 2013-07-31

Family

ID=40378881

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20130618AT HRP20130618T1 (en) 2007-08-22 2013-07-02 Methods of using mirna for detection of in vivo cell death

Country Status (17)

Country Link
US (4) US8486626B2 (hr)
EP (2) EP2612926B1 (hr)
JP (1) JP5416110B2 (hr)
CN (2) CN105400868B (hr)
AU (2) AU2008289447B2 (hr)
CA (1) CA2696403C (hr)
CY (1) CY1114111T1 (hr)
DK (2) DK2612926T3 (hr)
ES (2) ES2415245T5 (hr)
HK (1) HK1218767A1 (hr)
HR (1) HRP20130618T1 (hr)
HU (1) HUE019019T5 (hr)
NO (1) NO2612926T3 (hr)
PL (2) PL2195450T3 (hr)
PT (2) PT2195450E (hr)
TR (1) TR201802758T4 (hr)
WO (1) WO2009025852A2 (hr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009132273A2 (en) * 2008-04-25 2009-10-29 Merck & Co., Inc. Microrna biomarkers of tissue injury
WO2010004562A2 (en) * 2008-07-09 2010-01-14 Rosetta Genomics Ltd. Methods and compositions for detecting colorectal cancer
ES2595489T3 (es) * 2008-07-18 2016-12-30 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
EP2419536A4 (en) * 2009-04-14 2012-09-05 Merck Sharp & Dohme MICRO RNA AS A BIOMARKER FOR THE MOBILIZATION OF CELLS BETA OF PANCREATIC ISLANDS
WO2011006119A2 (en) 2009-07-09 2011-01-13 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
WO2011057003A2 (en) * 2009-11-04 2011-05-12 Samuil Umansky Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases
EP2496720B1 (en) 2009-11-06 2020-07-08 The Board of Trustees of the Leland Stanford Junior University Non-invasive diagnosis of graft rejection in organ transplant patients
US20140227691A1 (en) * 2010-05-14 2014-08-14 Fluidigm, Inc. Nucleic acid isolation methods
CN105861712B (zh) * 2011-04-18 2021-05-14 迪阿米尔有限责任公司 使用来自体液的miRNA来早期检测和监控轻度认知障碍(MCI)和阿尔茨海默病(AD)的方法
CN102188719B (zh) * 2011-05-12 2012-12-19 南方医科大学 EB病毒miR-BART3反义寡聚核苷酸在制备治疗鼻咽癌的药物中的应用
BR112013033488B8 (pt) * 2011-06-27 2022-11-22 Eisai R&D Man Co Ltd Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit
WO2013022953A2 (en) * 2011-08-08 2013-02-14 Eugenia Wang Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
CA3067612A1 (en) * 2011-09-22 2013-03-28 Lineage Biosciences, Inc. Compositions and methods for analyzing heterogeneous samples
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
SG11201505515XA (en) 2012-01-27 2015-09-29 Univ Leland Stanford Junior Methods for profiling and quantitating cell-free rna
US20140087964A1 (en) * 2012-09-24 2014-03-27 University Of Virginia Patent Foundation Compositions and methods for detecting aberrant regulation, expression, and levels of hgh
CN104903468B (zh) * 2012-11-16 2019-04-23 萨尔大学 用于帕金森氏病的新诊断MiRNA标志物
EP2733219B1 (en) 2012-11-16 2017-09-20 Siemens Aktiengesellschaft Diagnostic miRNA markers for Alzheimer
EP2733220B1 (en) 2012-11-16 2017-10-18 Siemens Aktiengesellschaft Novel miRNA as a diagnostic marker for Alzheimer's Disease
CN103045596A (zh) * 2012-12-20 2013-04-17 徐勇 唐氏综合征21号染色体相关miRNA、基因、筛选方法和应用
CN103045736B (zh) * 2012-12-20 2014-09-17 徐勇 唐氏综合征21号染色体miRNA差异表达图谱模型、构建方法及应用
EP2759602A1 (en) 2013-01-25 2014-07-30 Charité - Universitätsmedizin Berlin Non-invasive prenatal genetic diagnostic methods
EP3415626B1 (en) 2013-03-15 2020-01-22 Lineage Biosciences, Inc. Methods and compositions for tagging and analyzing samples
CA2931082C (en) 2013-11-18 2024-01-23 Diamir, Llc Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd)
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
TWI758011B (zh) 2014-07-18 2022-03-11 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
CN107922971A (zh) 2015-05-18 2018-04-17 凯锐思公司 用于富集核酸群体的组合物和方法
US10428391B2 (en) 2015-07-27 2019-10-01 The Johns Hopkins University Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: PCR and sequencing based process methods
US20180355346A1 (en) * 2015-09-11 2018-12-13 Corning Incorporated Compositions and methods for nucleic acid purification from blood samples
US10975436B2 (en) 2016-01-05 2021-04-13 Diamir, Llc Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders
US11149313B2 (en) 2016-03-21 2021-10-19 Diamir, Llc Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases
WO2018045359A1 (en) * 2016-09-02 2018-03-08 Karius, Inc. Detection and treatment of infection during pregnancy
EP3538095A4 (en) 2016-11-14 2020-06-17 Berg LLC METHOD FOR TREATING MORBUS PARKINSON
EP3548632A4 (en) 2016-11-30 2020-06-24 The Chinese University Of Hong Kong ANALYSIS OF CELLULAR DNA IN URINE AND OTHER SAMPLES
US10907211B1 (en) 2017-02-16 2021-02-02 Quantgene Inc. Methods and compositions for detecting cancer biomarkers in bodily fluids
US10781487B2 (en) 2017-07-24 2020-09-22 Diamir, Llc miRNA-based methods for detecting and monitoring aging
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
JP7389437B2 (ja) * 2019-10-29 2023-11-30 国立研究開発法人国立循環器病研究センター 脳梗塞治療支援システム
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856088A (en) 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US5168039A (en) 1990-09-28 1992-12-01 The Board Of Trustees Of The University Of Arkansas Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis
US6020124A (en) 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
ATE185152T1 (de) 1993-07-20 1999-10-15 Roche Diagnostics Gmbh Melanom-inhibierendes protein
WO1995004140A1 (en) 1993-07-28 1995-02-09 Akzo Nobel N.V. Process for isolating nucleic acid from gram positive microorganisms
DE69433425T2 (de) 1993-08-30 2004-10-07 Promega Corp Zusammensetzungen und verfahren zur reinigung von nukleinsäuren
US5631130A (en) 1994-05-13 1997-05-20 Abbott Laboratories Materials and methods for the detection of Mycobacterium tuberculosis
PT771360E (pt) 1994-06-09 2004-07-30 Innogenetics Nv Metodo para a deteccao do espectro de resistencia a antibioticos de especies mycobacterium
US5731150A (en) 1995-11-01 1998-03-24 Chiron Diagnostic Corporation IS6110 based molecular detection of mycobacterium tuberculosis
US6027945A (en) 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
US6492144B1 (en) 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
US20020119478A1 (en) 1997-05-30 2002-08-29 Diagen Corporation Methods for detection of nucleic acid sequences in urine
ES2260837T3 (es) 1997-05-30 2006-11-01 Xenomics Procedimiento para detectar secuencias de acidos nucleicos en la orina.
US5962665A (en) 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US20060204989A1 (en) † 1998-09-22 2006-09-14 Kopreski Michael S Comparative analysis of extracellular RNA species
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20040053264A1 (en) 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips
EP2471922A1 (en) * 2004-05-28 2012-07-04 Asuragen, Inc. Methods and compositions involving microRNA
ITRM20050067A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
EP2351857B1 (en) 2005-02-17 2014-10-29 TrovaGene, Inc. Compositions and methods for detecting pathogen specific nucleic acids in urine
ITRM20050068A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
US7914982B2 (en) 2005-02-17 2011-03-29 Trovagene, Inc. Methods for detecting pathogen specific nucleic acids in urine
WO2006089203A2 (en) 2005-02-17 2006-08-24 Istituto Nazionale Per Le Malattie Infettive Irccs Lazzaro Spallanzani Compositions and methods for detecting viral specific nucleic acids in urine
US20060292616A1 (en) * 2005-06-23 2006-12-28 U.S. Genomics, Inc. Single molecule miRNA-based disease diagnostic methods
DE102005059315A1 (de) * 2005-12-09 2007-06-14 Qiagen Gmbh Verfahren zur Anreicherung von kurzkettigen Nukleinsäuren
US20070202511A1 (en) * 2006-02-28 2007-08-30 Sigma-Aldrich Co. Methods and compositions for the rapid isolation of small RNA molecules
ES2595489T3 (es) 2008-07-18 2016-12-30 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR

Also Published As

Publication number Publication date
PT2195450E (pt) 2013-07-10
CN105400868A (zh) 2016-03-16
US20150197805A1 (en) 2015-07-16
EP2195450A2 (en) 2010-06-16
US20180135126A1 (en) 2018-05-17
CY1114111T1 (el) 2016-07-27
AU2008289447B2 (en) 2014-09-04
PL2195450T3 (pl) 2013-09-30
CA2696403A1 (en) 2009-02-26
JP2010536372A (ja) 2010-12-02
US20200283851A1 (en) 2020-09-10
EP2195450B2 (en) 2016-07-20
AU2008289447A1 (en) 2009-02-26
ES2660785T3 (es) 2018-03-26
EP2195450B1 (en) 2013-04-03
PL2612926T3 (pl) 2018-07-31
AU2014210676B2 (en) 2017-04-06
EP2612926B1 (en) 2017-11-29
DK2195450T4 (en) 2016-10-24
CA2696403C (en) 2018-01-02
HK1218767A1 (zh) 2017-03-10
US20090081640A1 (en) 2009-03-26
TR201802758T4 (tr) 2018-03-21
CN101861399B (zh) 2015-11-25
JP5416110B2 (ja) 2014-02-12
ES2415245T5 (es) 2016-12-23
WO2009025852A2 (en) 2009-02-26
DK2195450T3 (da) 2013-06-24
AU2014210676A1 (en) 2014-08-28
CN105400868B (zh) 2021-03-26
US8486626B2 (en) 2013-07-16
ES2415245T3 (es) 2013-07-24
EP2612926A1 (en) 2013-07-10
CN101861399A (zh) 2010-10-13
WO2009025852A3 (en) 2009-05-07
DK2612926T3 (en) 2018-03-12
NO2612926T3 (hr) 2018-04-28
HUE019019T5 (en) 2017-04-28
PT2612926T (pt) 2018-03-02

Similar Documents

Publication Publication Date Title
HRP20130618T1 (en) Methods of using mirna for detection of in vivo cell death
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2010091049A3 (en) Diagnosis and treatment of cancer
EP4219760A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
EP4218570A3 (en) Polymer membranes for continuous analyte sensors
WO2012061835A3 (en) Apparatus and method for non-invasively detecting diseases that affect structural properties in biological tissues
HK1208530A1 (en) Integrated blood glucose measurement device
MX361944B (es) Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales.
MX2010014228A (es) Metodos y productos de diagnostico del p/gf-1 acompañante.
HK1171506A1 (en) Blood glucose meter and blood glucose level measurement method
WO2012050602A3 (en) Oral engagement assemblies
HK1172533A1 (en) Body fluid lancing, acquiring, and testing cartridge design
GB2467467B (en) TAZ/WWTR1 for diagnosis and treatment of cancer
WO2011028608A3 (en) Detecting neurochemical or electrical signals within brain tissue
WO2008131361A3 (en) Biosensors for measuring analytes in the interstitial fluid
IL202674A0 (en) Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma
WO2013011294A3 (en) Diagnosis of alzheimer's disease
WO2010033773A3 (en) Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways
PH12014502648A1 (en) Apparatuses for detecting and/or diagnosing swallowing disorders
EP2509488A4 (en) METHODS AND ARRANGEMENTS FOR THE ANALYSIS, DIAGNOSIS AND MONITORING OF VOCAL STRENGTH PROCESSING BY OPTICAL COHERENCE TOMOGRAPHY
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
WO2009064927A3 (en) Phosphorylated fatty acid synthase and cancer
WO2009022988A3 (en) Vhz for diagnosis and treatment of cancer
BR112012009859A2 (pt) composição de diagnóstico, método de diagnóstico, e, método de detecção de formação de imagem in vivo
EP2326247A4 (en) BLOOD GLUCOSE MEASURING DEVICE OF A LAPPED LASER AUTOPIC TYPE, BAND AND METHOD OF USING THE SAME